NRX PHARMACEUTICALS INC-CW22 (NRXPW) Stock News
NASDAQ:NRXPW - Nasdaq - - Currency: USD
NRXPW Latest News, Press Relases and Analysis
Morgan Stanley Stays Cautious on U.S. Steel (X), Expects Stock to Hit $55
On May 26, an analyst from Morgan Stanley reiterated his cautious stance on United States Steel Corp. (NYSE:X) with an Equal-Weight rating. The analyst expressed hope for progress in Nippon Steel Corp. (OTC:NPSCY)’s potential investment in the company following signals of approvals from President Trump regarding a partnership. However, the deal’s specifics remain unclear, and […]
Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) system, the first device of its kind approved in the US to treat mitral valve disease without open-heart surgery. Tendyne is specifically designed for patients who are not suitable candidates for surgical valve repair or replacement. The product perfectly […]
Pure Storage Partners with SK Hynix to Deliver Energy-Efficient Storage Products for Hyperscale Data Centers
Pure Storage, Inc. (NYSE:PSTG) announced today a strategic collaboration with SK hynix to develop high-capacity, energy-efficient flash storage tailored for hyperscale data centers. The partnership leverages PSTG’s DirectFlash architecture and SK hynix’s advanced QLC NAND technology to deliver superior low-latency solutions that are able to address hyperscalers’ mounting storage needs while cutting energy consumption. This […]
Mayville Engineering Company, Inc. (MEC) Seals $140M Accu-Fab Acquisition Deal
Mayville Engineering Company, Inc. (NYSE:MEC) has reached a definitive agreement to acquire Accu-Fab Inc. from Tide Rock Holdings LLC for $140.5 million. The all-cash transaction will be financed through borrowings under MEC’s existing $250 million syndicated credit facility, supported by Wells Fargo and JPMorgan Chase. Following regulatory approvals and customary closing conditions, the acquisition is […]
MicroStrategy-inspired KULR set to join Russell 3000 Index
KULR Technology is set to be added to the Russell 3000 Index on June 30, which is expected to increase its visibility and appeal among institutional investors.
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) has suspended dosing in its Danon disease gene therapy trial after a patient developed fatal complications from capillary leak syndrome, which caused a severe drop in blood pressure and led to an acute systemic infection. The FDA placed a formal clinical hold on the trial following the incident. The company is […]
Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal
Biogen Inc. (NASDAQ:BIIB)’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases has fueled a 6% rise in its share price over the past month, reflecting renewed investor optimism. This move comes amid a broader rally in the tech sector driven by favorable policy shifts and positive market sentiment, […]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and its subsidiary, HOPE Therapeutics, Inc., are making a major move in mental health care with the acquisition of Kadima Neuropsychiatry Institute in La Jolla, California. Announced today, the definitive agreement marks a strategic expansion for NRXP, positioning Kadima as the clinical model for HOPE’s planned network of interventional psychiatry clinics […]
Crypto's iPhone Moment: Why 2025 Marks the Breakout Into The Mainstream
Cryptocurrency adoption is approaching a critical inflection point in 2025, with global user penetration expected to surpass 11% according to Statista projections—up from 7.41% in 2024. This milestone represents far more than a statistical marker; it ...
Newly Minted ETFs Buck Vanguard Effect as Fees Hit Record High
(Bloomberg) -- Jack Bogle may have envisioned a world of rock-bottom fees and sleepy index funds — but the ETF market in 2025 looks more like a speculative arcade than a cost-cutting utopia.Most Read from BloombergUAE’s AI University Aims to Become Stanford of the GulfNY Wins Order Against US Funding Freeze in Congestion FightThe average fee of an exchange-traded fund launched this year has surged to a record 65 basis points, with leveraged trades, cryptocurrency, and active management among the
NRX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NRx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Mentions: NRXP
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NRx Pharmaceuticals, Inc, of Class Action Lawsuit and Upcoming Deadline - NRXP; NRXPW
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. ("NRx" or the "Company") (NASDAQ: NRXP)...
Mentions: NRXP
NRXP; NRXPW Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NRx Pharmaceuticals, Inc. Investors of Class Action and Lead Plaintiff Deadline: March 21, 2022
Mentions: NRXP
ALERT: NRx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NRXP; NRXPW
Mentions: NRXP
NRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NRx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Mentions: NRXP